ARCHIVES

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

Newell Describes Progress To House, Senate Subcommittees

March 25, 1977

Panel Objects To Act Change Requiring NCI Carcinogen Report

May 12, 1978

Is a New Cancer Center Always a Good Thing? UCSD To Buy Las Vegas Center at Bankruptcy Sale

January 20, 2012

IOM Report Links Agent Orange, CLL

January 24, 2003

NCI Implementing Changes In Organ Site Program, Directing Grant applications To NIH Study Sections

October 15, 1982